Hong Kong approves BioNTech vaccine
The regional government in Hong Kong has approved emergency use of the BioNTech vaccine against the deadly coronavirus, Anadolu Agency reports.
The city-state's Health Department said the BioNTech COVID-19 vaccine has been approved for emergency use in a statement released on Monday night.
Shanghai-based Fosun Pharma has acquired the German BioNTech COVID-19 vaccine and Hong Kong’s health advisory panel had last week approved its use.
The statement said the BioNTech vaccine's benefits “outweigh the risks”, referring to the criteria of “safety, efficacy and quality.”
However, it added that the pharmaceutical companies have to continuously submit the latest clinical data, safety update reports, and the quality certification of each batch of jabs manufactured.
The first batch of one million doses of the vaccine is “being tested for its safety and quality and will likely be shipped from Germany to Hong Kong late next month.”
In recent weeks, Hong Kong witnessed a surge in COVID-19 cases triggering mass clinical testing. The authorities also imposed a limited lockdown in the region’s most populated Yau Tsim Mong district.
She added Hong Kong has “a desperate need for vaccination among high-risk groups and cross-border workers.”
The region has reported over 10,000 cases of the virus, including 170 deaths since the outbreak.